All Featured Insights

UnitedHealth Group stock drops, eight artificial food dyes to be phased out, Eli Lilly oral GLP-1 pill has promising Phase 3 result

NIH makes cuts to administrative funds, House GOP seeks to make large healthcare spending cuts, some federal healthy agencies’ webpages restored.

RFK Jr. clears Senate panel, federal and state policy battle over transgender care comes to head in New York, Moody’s downgrades health insurer credit outlook

OMB memo causes significant confusion, Change cyberattack affected 190 million people, Cigna to limit out-of-pocket drug costs.

Next round of drugs for Medicare drug price negotiations announced, Trump health policy actions in second term, ACA exchanges see record enrollment in 2025

SCOTUS to hear challenge to ACA preventive care mandate, DEA proposes telehealth rule for controlled substances, FDA announces three regulations

Congress negotiates its year-end healthcare package, Dreamers lose access to ACA exchanges, and Elevance reverses its controversial anesthesia policy.

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures.

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again.

CMS finalizes the 2025 OPPS rule, an appeals court rules reverses a No Surprises Act decision, and MACPAC calls for more Medicaid payment oversight.

The FTC finalizes its premerger notification rule, Walgreens announces over 1K closures, and providers win a large antitrust class action settlement.

VP Harris proposes that Medicare cover home health aides, four health systems launch a new company, and CMS releases its initial list for $2 generic drugs.